One concern is that, although we demonstrated promotion of OSCC migration and invasion by manipulation of IGF2BP2 levels in in vitro experiments, the effects of this RNA-binding protein on oral cancer progression may be different within complex tumor microenvironments in in vivo settings. This evidence concerns the gene IGF2BP2 and neoplasm.